Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
With
University of Manchester
University of Oxford
Age
18–45
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Documented clinical diagnosis meeting criteria from the DSM-IV by structured clinical interview,major depressive disorder, single episode or recurrent
Outpatient status at screening and at randomisation
You may not be if
A major depression disorder which has a major impact on the subjects current psychiatric status
Subjects not allowed to use mood stabilizers, antidepressants or other antipsychotic or psychoactive drugs
Subjects with lifetime history of schizophrenia, bi-polar, psychosis and psychotic depression
Clareo Health | Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects
